Colgate-Palmolive Chairman & CEO Noel Wallace Granted Annual Equity Awards

Executive Summary

On September 18, 2026, Colgate-Palmolive Co ($CL) filed a Form 4 reporting annual equity incentive grants awarded to Chairman, President, and Chief Executive Officer Noel R. Wallace. The awards, dated September 16, 2026, consist of both restricted stock units (RSUs) and stock options granted under the company's incentive compensation plan.

Transaction Breakdown

• Restricted Stock Units: Wallace was awarded 29,649 shares of Common Stock at an acquisition price of $0.00. Following this transaction, his direct beneficial ownership reached 379,700 common shares. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant date.
• Stock Options: In Table II, Wallace received options to purchase 205,197 shares of Common Stock with an exercise price of $87.02 per share, expiring September 16, 2036. The options also vest in three equal annual installments starting on the first anniversary.
• Indirect Ownership: In addition to direct holdings, Wallace maintains indirect beneficial ownership of 54,868 shares via the 401(k) Plan Trustee, 52,000 shares via a spouse trust, and 335 shares held in trust.

Market Significance

This filing represents standard long-term equity incentive compensation rather than an open-market purchase or sale. Because the shares and options were acquired via company grants at zero acquisition cost as part of routine executive compensation, this event carries a Low market trading significance.